openPR Logo
Press release

France Diabetes Market to be USD 3.38 Billion by 2028

08-17-2023 01:09 PM CET | Health & Medicine

Press release from: Renub Resaecrh

According to Renub Research latest report, "France Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Share, Growth, Company Analysis," France's Diabetes Market is estimated to grow at a CAGR of 2.72% and reach US$ 3.38 Billion by 2028. France is among the top five countries in the European region with the highest incidence of diabetes. According to the International Diabetes Federation Report, 2017, approximately 66 Million people in Europe suffer from diabetes, which will go up to 81 million by 2045. The prevalence of diabetes is rising among all ages in France.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/france-diabetes-market-p.php

The rise is due to the growing obese population and unhealthy diets and lifestyles. Nearly a million people have been diagnosed with diabetes in France, according to the World Health Organization (WHO). Thus, the rising prevalence of diabetes and obesity, growing awareness regarding diabetic care, healthcare expenditure, and technological advancements are a few factors that drive the market for diabetes drugs in France. In France, there is a centralized health care system their all the reimbursement decisions are taken at a national level and then applied to all the countries.

Prevalence of Type 2 Diabetes will Rise:

The factors such as rising research and development activities, as well as the rising prevalence of obesity, are propelling the demand for type 2 diabetes drugs. In addition, improved supply chain management is providing lucrative opportunities to expand the France type 2 diabetes market. According to a survey by the EU Commission, the number of individuals in France who have chronic diabetes is the greatest, and one in 10 people in France has diabetes.

Government Initiatives assist in the Management of Diabetes:

Chronic diseases, especially diabetes mellitus, are a significant priority for the French National Health Insurance (CNAMTS). The goal of the SOPHIA program is to improve the health status and the quality of life of people with diabetes and to reduce healthcare expenditure by reducing complications and comorbidity frequency. To achieve this, SOPHIA provides a comprehensive program of support, addressing both type 1 and type 2 diabetes patients, building on the pivotal role of the general physician (GP) in the healthcare system and helping them to coordinate care for their patients.

SMBG has Superiority in the Market Share due to the Rise in the Diabetes Population

Driving factors that help the dominance of SMBG market share are the increasing diabetic population in the country, Governments' and NGOs' efforts to increase awareness, increasing per capita healthcare expenditure, and availability of reimbursements in the country. For instance, France's statutory health insurance (SHI) covers 100% of it, and the number of covered patients has doubled in the past ten years. The development of technologically enhanced SMBG devices augmented with mobility, high precision, and increased dependability will positively impact device adoption.

Demand for sophisticated SMBG devices will increase as a less invasive and integrated device for disease monitoring grows. Additionally, investments in research and development result in new product launches and increased knowledge of diabetes care and management. Furthermore, technologically advanced portable and small devices offer ease in handling patients.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=france-diabetes-market-p.php

Competitive Landscape:

Major players competing in the France Diabetes Market are; B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp., Dexcom Inc., Roche Diagnostic, and Tandem Diabetes Care.

Market Summary:

• Devices - Report covers France's Diabetes Market by devices in 3 viewpoints (SMBG, CGM, and Insulin Pumps).
• Key Players - All the major players have been covered from 3 Viewpoints (Company Overview, Recent Developments, and Financial Insights) B. Braun Melsungen AG, Eli Lilly and Company, Terumo Corporation, Becton, Dickenson (BD), Novo Nordisk A/S, Ypsomed AG, Medtronic, Insulet Corporation, Abbott Laboratories, DarioHealth Corp., Dexcom Inc., Roche Diagnostic, and Tandem Diabetes Care.

Related Reports

Japan Diabetes Market: https://www.renub.com/japan-diabetes-market-p.php
Canada Diabetes Market: https://www.renub.com/canada-insulin-pump-cgm-market-p.php
Switzerland Diabetes Market: https://www.renub.com/switzerland-diabetes-market-p.php
Sweden Diabetes Market: https://www.renub.com/sweden-diabetes-market-p.php
United States Diabetes Market: https://www.renub.com/united-states-diabetes-market-p.php

About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release France Diabetes Market to be USD 3.38 Billion by 2028 here

News-ID: 3168816 • Views:

More Releases from Renub Resaecrh

Global Sports Medicine Market to Hit $12.32 Billion by 2033, Driven by Rising At …
Sports Medicine Market Overview The growing awareness of injury prevention, increased involvement in sports and physical activities, and advancements in medical technology are all contributing to the notable rise of the global sports medicine industry. The prevention, diagnosis, treatment, and rehabilitation of sports-related injuries are the primary goals of this specialized discipline, which serves athletes, fitness enthusiasts, and individuals who lead active lifestyles. The adoption of less invasive surgical procedures, the
U.S. Cosmetics Industry Set to Surge Past $149 Billion by 2033 Amid Rising Demand for Clean Beauty and Innovation
U.S. Cosmetics Industry Set to Surge Past $149 Billion by 2033 Amid Rising Deman …
United States Cosmetics Market Overview According to Renub Research, with an absolute compound annual growth rate (CAGR) of 4.82% from 2025 to 2033, the United States cosmetics industry is expected to reach around US$ 149.53 billion in 2033, up from US$ 97.89 billion in 2024. Growing consumer awareness of personal grooming and beauty improvement, particularly among millennial and Gen Z, is the primary factor driving the US industry. For example, according to
Global Non-Invasive Prenatal Testing Market to Triple by 2033, Surging to US$ 11.36 Billion at 13.55% CAGR
Global Non-Invasive Prenatal Testing Market to Triple by 2033, Surging to US$ 11 …
Non-Invasive Prenatal Testing Market Overview A type of prenatal screening called non-invasive prenatal testing (NIPT) uses a pregnant woman's blood sample to check for fetal abnormalities. By examining DNA fragments in the mother's blood, the test is primarily used to identify genetic abnormalities, such as Turner syndrome, Patau syndrome, Edwards syndrome, and Down syndrome. The treatment, which may be carried out after nine weeks of pregnancy, removes the need
Renub Research: Global Tractor Market Set to Plough Ahead, Reaching $111.22 Billion by 2033
Renub Research: Global Tractor Market Set to Plough Ahead, Reaching $111.22 Bill …
Agricultural Tractors Market Overview The growing need for automated solutions in contemporary farming is driving the rapid evolution of the agricultural tractor market. Precision agriculture, less manual work, and increased output are all made possible by tractors. To maximize field operations, farmers are implementing tractors equipped with cutting-edge technology, such as automation, telematics, and GPS, as the global demand for food increases. Trends such as climate change adaptation and sustainable

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end